Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
Total Debt/Equity

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Total Debt/Equity History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Total Debt/Equity(x) 0.200.240.210.180.10

What is the latest Total Debt/Equity ratio of AUROBINDO PHARMA ?

The latest Total Debt/Equity ratio of AUROBINDO PHARMA is 0.20 based on Mar2026 Consolidated results.
Year Total Debt/Equity
Mar20260.20
Mar20250.24
Mar20240.21
Mar20230.18
Mar20220.10

How is Total Debt/Equity of AUROBINDO PHARMA Trending?

Years Total Debt/Equity % Change
Mar2026 0.2
-16.67
Mar2025 0.24
14.29
Mar2024 0.21
16.67
Mar2023 0.18
80.00
Mar2022 0.1 -

Other Financial Ratios of AUROBINDO PHARMA


Compare Total Debt/Equity ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹94,423.1 Cr -2.9% 1% 58.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,717.0 Cr -0.8% -1.5% 15.1% Stock Analytics
DIVIS LABORATORIES ₹244,223.0 Cr -3% 8.3% 52.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹183,453.0 Cr -2.2% -1.5% 35% Stock Analytics
CIPLA ₹109,849.0 Cr -0.6% -4.9% -13% Stock Analytics
DR REDDYS LABORATORIES ₹95,591.8 Cr 0.2% -3.9% -11.8% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-2.9%

1%

58.5%

SENSEX

-1.6%

-4.7%

-8.3%


You may also like the below Video Courses